National Cancer Institute
Schedules
TAFS: 075-0849 /X - National Cancer Institute
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1000 | DE | Discretionary Expected - Unob Bal: Brought Forward, Oct 1 | $279,000,000.00 | See footnotes below |
| Footnotes for line 1000 (DE): | B1: Pursuant to P. L. 116-260 in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001. A total unobligated balance of $170,000,000 will be brought forward to October 1, 2021. B2: Transfer from the Public Health and Social Services Emergency Fund (PHSSEF) pursuant to the Paycheck Protection Program and Health Care Enhancement Act (PL 116-139). A total unobligated balance of $109,000,000 will be brought forward to October 1, 2021. | |||
| 1000 | ME | Mandatory Expected: Unob Bal - Brought Forward, Oct 1 | $14,706,400.00 | See footnotes below |
| Footnotes for line 1000 (ME): | B3: Pursuant to the National Defense Authorization Act for Fiscal Year 2020 (P.L. 116-92) Section 1737 Extension of Postage Stamp for Breast Cancer Research) and the P.L. 114-255 Section 2043 as authorized by section 301 of the Public Health Service Act, a total unobligated balance for Breast Cancer Stamp of $14,500,000 will be brought forward to October 1, 2021. The remaining $206,400 is the total unobligated balance brought forward for Research Resources to October 1, 2021. The total unobligated balance for both Breast Cancer Stamp and Research Resources is $14,706,400 which will be brought forward to October 1, 2021. | |||
| 1061 | DE | Unob Bal: Antic recov of prior year unpd/pd obl | $30,000,000.00 | |
| 1061 | ME | Unob Bal: Antic recov of prior year unpd/pd obl | $500,000.00 | |
| 1840 | BA: Mand: Spending auth:Antic colls, reimbs, other | $2,700,000.00 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $326,906,400.00 | ||
| 6001 | Category A -- 1st quarter | $14,706,400.00 | ||
| 6002 | Category A -- 2nd quarter | $1,200,000.00 | ||
| 6003 | Category A -- 3rd quarter | $1,000,000.00 | ||
| 6004 | Category A -- 4th quarter | $1,000,000.00 | ||
| 6011 | NIH Innovation, CURES Act | $185,000,000.00 | ||
| 6012 | NCI Coronavirus response | $124,000,000.00 | See footnotes below | |
| Footnotes for line 6012: | A3: HHS will inform OMB in writing five business days in advance of any deviations from NIH's activities or funding in HHS's most recent Congressional spend plan provided as required in Public Law 116-139. | |||
| 6190 | Total budgetary resources available | $326,906,400.00 | See footnotes below | |
| Footnotes for line 6190: | A1: Details on attachments are not subject to 31 U.S.C. 1517. The term "attachments" includes but is not limited to the worksheets in this Excel file that accompany the SF 132 and this footnote worksheet. A2: The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. | |||
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
| Number | Text |
|---|---|
| A1 | Details on attachments are not subject to 31 U.S.C. 1517. The term "attachments" includes but is not limited to the worksheets in this Excel file that accompany the SF 132 and this footnote worksheet. |
| A2 | The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. |
| A3 | HHS will inform OMB in writing five business days in advance of any deviations from NIH's activities or funding in HHS's most recent Congressional spend plan provided as required in Public Law 116-139. |
| B1 | Pursuant to P. L. 116-260 in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001. A total unobligated balance of $170,000,000 will be brought forward to October 1, 2021. |
| B2 | Transfer from the Public Health and Social Services Emergency Fund (PHSSEF) pursuant to the Paycheck Protection Program and Health Care Enhancement Act (PL 116-139). A total unobligated balance of $109,000,000 will be brought forward to October 1, 2021. |
| B3 | Pursuant to the National Defense Authorization Act for Fiscal Year 2020 (P.L. 116-92) Section 1737 Extension of Postage Stamp for Breast Cancer Research) and the P.L. 114-255 Section 2043 as authorized by section 301 of the Public Health Service Act, a total unobligated balance for Breast Cancer Stamp of $14,500,000 will be brought forward to October 1, 2021. The remaining $206,400 is the total unobligated balance brought forward for Research Resources to October 1, 2021. The total unobligated balance for both Breast Cancer Stamp and Research Resources is $14,706,400 which will be brought forward to October 1, 2021. |
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.